Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status

Standard

Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status. / Landahl, Johanna; Bockmann, Jan Hendrik; Scheurich, Christoph; Ackermann, Christin; Matzat, Verena; Heide, Janna; Nuurei, Tungalag; D'Antonio, Gianluca; von Felden, Johann; Sette, Alessandro; Peine, Sven; Lohse, Ansgar W; Lütgehetmann, Marc; Marget, Matthias; Sidney, John; Schulze Zur Wiesch, Julian.

in: J INFECT DIS, Jahrgang 219, Nr. 4, 29.01.2019, S. 568-577.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{063d2eec3c6344df85d39084a8651845,
title = "Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status",
abstract = "Background: This study aimed to comprehensively define the breadth and specificity of the hepatitis delta virus (HDV)-specific T-cell response in patients at different stages of chronic coinfection with hepatitis B virus (HBV).Methods: Following in vitro stimulation with an overlapping set of 21 HDV-specific 20mer peptides and exogenous interleukin 2, HDV-specific CD4+ and CD8+ T-cell responses of 32 HDV-infected patients were analyzed by enzyme-linked immunospot analysis and intracellular cytokine staining for interferon γ production at the single-peptide level. Additionally, HLA-binding studies were performed both in silico and in vitro.Results: We were able to detect ≥1 T-cell response in >50% our patients. Interestingly, there was no significant difference between the breadth of the response in patients positive and those negative for HDV by PCR. HDV-specific T-cell responses focused on 3 distinct HDV-specific epitopes that were each detected in 12%-21% of patients-2 HLA class II-restricted epitopes (amino acids 11-30 and 41-60) and 1 major histocompatibility complex class I-restricted epitope (amino acids 191-210). In in vitro HLA-binding assays, the 2 CD4+ T-cell specificities (amino acids 11-30 and 41-60) showed promiscuous binding to multiple HLA-DR molecules.Conclusions: This comprehensive characterization of HDV T-cell epitopes provides important information that will facilitate further studies of HDV immunopathogenesis.",
keywords = "Journal Article",
author = "Johanna Landahl and Bockmann, {Jan Hendrik} and Christoph Scheurich and Christin Ackermann and Verena Matzat and Janna Heide and Tungalag Nuurei and Gianluca D'Antonio and {von Felden}, Johann and Alessandro Sette and Sven Peine and Lohse, {Ansgar W} and Marc L{\"u}tgehetmann and Matthias Marget and John Sidney and {Schulze Zur Wiesch}, Julian",
year = "2019",
month = jan,
day = "29",
doi = "10.1093/infdis/jiy549",
language = "English",
volume = "219",
pages = "568--577",
journal = "J INFECT DIS",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status

AU - Landahl, Johanna

AU - Bockmann, Jan Hendrik

AU - Scheurich, Christoph

AU - Ackermann, Christin

AU - Matzat, Verena

AU - Heide, Janna

AU - Nuurei, Tungalag

AU - D'Antonio, Gianluca

AU - von Felden, Johann

AU - Sette, Alessandro

AU - Peine, Sven

AU - Lohse, Ansgar W

AU - Lütgehetmann, Marc

AU - Marget, Matthias

AU - Sidney, John

AU - Schulze Zur Wiesch, Julian

PY - 2019/1/29

Y1 - 2019/1/29

N2 - Background: This study aimed to comprehensively define the breadth and specificity of the hepatitis delta virus (HDV)-specific T-cell response in patients at different stages of chronic coinfection with hepatitis B virus (HBV).Methods: Following in vitro stimulation with an overlapping set of 21 HDV-specific 20mer peptides and exogenous interleukin 2, HDV-specific CD4+ and CD8+ T-cell responses of 32 HDV-infected patients were analyzed by enzyme-linked immunospot analysis and intracellular cytokine staining for interferon γ production at the single-peptide level. Additionally, HLA-binding studies were performed both in silico and in vitro.Results: We were able to detect ≥1 T-cell response in >50% our patients. Interestingly, there was no significant difference between the breadth of the response in patients positive and those negative for HDV by PCR. HDV-specific T-cell responses focused on 3 distinct HDV-specific epitopes that were each detected in 12%-21% of patients-2 HLA class II-restricted epitopes (amino acids 11-30 and 41-60) and 1 major histocompatibility complex class I-restricted epitope (amino acids 191-210). In in vitro HLA-binding assays, the 2 CD4+ T-cell specificities (amino acids 11-30 and 41-60) showed promiscuous binding to multiple HLA-DR molecules.Conclusions: This comprehensive characterization of HDV T-cell epitopes provides important information that will facilitate further studies of HDV immunopathogenesis.

AB - Background: This study aimed to comprehensively define the breadth and specificity of the hepatitis delta virus (HDV)-specific T-cell response in patients at different stages of chronic coinfection with hepatitis B virus (HBV).Methods: Following in vitro stimulation with an overlapping set of 21 HDV-specific 20mer peptides and exogenous interleukin 2, HDV-specific CD4+ and CD8+ T-cell responses of 32 HDV-infected patients were analyzed by enzyme-linked immunospot analysis and intracellular cytokine staining for interferon γ production at the single-peptide level. Additionally, HLA-binding studies were performed both in silico and in vitro.Results: We were able to detect ≥1 T-cell response in >50% our patients. Interestingly, there was no significant difference between the breadth of the response in patients positive and those negative for HDV by PCR. HDV-specific T-cell responses focused on 3 distinct HDV-specific epitopes that were each detected in 12%-21% of patients-2 HLA class II-restricted epitopes (amino acids 11-30 and 41-60) and 1 major histocompatibility complex class I-restricted epitope (amino acids 191-210). In in vitro HLA-binding assays, the 2 CD4+ T-cell specificities (amino acids 11-30 and 41-60) showed promiscuous binding to multiple HLA-DR molecules.Conclusions: This comprehensive characterization of HDV T-cell epitopes provides important information that will facilitate further studies of HDV immunopathogenesis.

KW - Journal Article

U2 - 10.1093/infdis/jiy549

DO - 10.1093/infdis/jiy549

M3 - SCORING: Journal article

C2 - 30247653

VL - 219

SP - 568

EP - 577

JO - J INFECT DIS

JF - J INFECT DIS

SN - 0022-1899

IS - 4

ER -